Coloplast A/S (CLPBF) Stock Competitors & Peer Comparison
See (CLPBF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLPBF | $57.56 | -0.14% | 11.9B | 39.70 | $1.45 | +6.22% |
| SEMHF | $39.67 | +0.88% | 44.4B | 18.11 | $2.19 | +3.00% |
| FUJIY | $10.82 | +0.84% | 26.1B | 15.44 | $0.70 | +1.79% |
| RYLPF | $25.99 | -0.28% | 25.2B | 22.41 | $1.16 | +3.83% |
| RSMDF | $16.99 | -5.24% | 24.6B | 16.34 | $1.04 | +1.22% |
| FUJIF | $20.00 | -4.03% | 23.9B | 14.29 | $1.40 | +2.28% |
| SMMNY | $20.22 | +2.33% | 22.6B | 18.59 | $1.09 | +2.93% |
| SONVF | $268.00 | -2.76% | 15.9B | 23.55 | $11.38 | +2.02% |
| SONVY | $51.62 | -0.08% | 15.4B | 22.87 | $2.26 | +2.09% |
| CLPBY | $6.06 | +2.36% | 13.7B | 40.40 | $0.15 | +5.94% |
Stock Comparison
CLPBF vs SEMHF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SEMHF has a market cap of 44.4B. Regarding current trading prices, CLPBF is priced at $57.56, while SEMHF trades at $39.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SEMHF's P/E ratio is 18.11. In terms of profitability, CLPBF's ROE is +0.14%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, CLPBF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check SEMHF's competition here
CLPBF vs FUJIY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, FUJIY has a market cap of 26.1B. Regarding current trading prices, CLPBF is priced at $57.56, while FUJIY trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas FUJIY's P/E ratio is 15.44. In terms of profitability, CLPBF's ROE is +0.14%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, CLPBF is less volatile compared to FUJIY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check FUJIY's competition here
CLPBF vs RYLPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RYLPF has a market cap of 25.2B. Regarding current trading prices, CLPBF is priced at $57.56, while RYLPF trades at $25.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RYLPF's P/E ratio is 22.41. In terms of profitability, CLPBF's ROE is +0.14%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, CLPBF and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
CLPBF vs RSMDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RSMDF has a market cap of 24.6B. Regarding current trading prices, CLPBF is priced at $57.56, while RSMDF trades at $16.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RSMDF's P/E ratio is 16.34. In terms of profitability, CLPBF's ROE is +0.14%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, CLPBF and RSMDF have similar daily volatility (0.00).Check RSMDF's competition here
CLPBF vs FUJIF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, FUJIF has a market cap of 23.9B. Regarding current trading prices, CLPBF is priced at $57.56, while FUJIF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas FUJIF's P/E ratio is 14.29. In terms of profitability, CLPBF's ROE is +0.14%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, CLPBF and FUJIF have similar daily volatility (0.00).Check FUJIF's competition here
CLPBF vs SMMNY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SMMNY has a market cap of 22.6B. Regarding current trading prices, CLPBF is priced at $57.56, while SMMNY trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SMMNY's P/E ratio is 18.59. In terms of profitability, CLPBF's ROE is +0.14%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, CLPBF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check SMMNY's competition here
CLPBF vs SONVF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, CLPBF is priced at $57.56, while SONVF trades at $268.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SONVF's P/E ratio is 23.55. In terms of profitability, CLPBF's ROE is +0.14%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, CLPBF and SONVF have similar daily volatility (0.00).Check SONVF's competition here
CLPBF vs SONVY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SONVY has a market cap of 15.4B. Regarding current trading prices, CLPBF is priced at $57.56, while SONVY trades at $51.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SONVY's P/E ratio is 22.87. In terms of profitability, CLPBF's ROE is +0.14%, compared to SONVY's ROE of +0.22%. Regarding short-term risk, CLPBF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check SONVY's competition here
CLPBF vs CLPBY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CLPBY has a market cap of 13.7B. Regarding current trading prices, CLPBF is priced at $57.56, while CLPBY trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CLPBY's P/E ratio is 40.40. In terms of profitability, CLPBF's ROE is +0.14%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, CLPBF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CLPBY's competition here
CLPBF vs SNNUF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, CLPBF is priced at $57.56, while SNNUF trades at $15.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SNNUF's P/E ratio is 20.97. In terms of profitability, CLPBF's ROE is +0.14%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, CLPBF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check SNNUF's competition here
CLPBF vs OCPNF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, CLPBF is priced at $57.56, while OCPNF trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas OCPNF's P/E ratio is 29.42. In terms of profitability, CLPBF's ROE is +0.14%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, CLPBF and OCPNF have similar daily volatility (0.00).Check OCPNF's competition here
CLPBF vs WILYY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, WILYY has a market cap of 8.5B. Regarding current trading prices, CLPBF is priced at $57.56, while WILYY trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas WILYY's P/E ratio is 23.05. In terms of profitability, CLPBF's ROE is +0.14%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, CLPBF and WILYY have similar daily volatility (0.00).Check WILYY's competition here
CLPBF vs WILLF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, WILLF has a market cap of 8.2B. Regarding current trading prices, CLPBF is priced at $57.56, while WILLF trades at $38.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas WILLF's P/E ratio is 22.29. In terms of profitability, CLPBF's ROE is +0.14%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, CLPBF and WILLF have similar daily volatility (0.00).Check WILLF's competition here
CLPBF vs YPHDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, YPHDF has a market cap of 5.8B. Regarding current trading prices, CLPBF is priced at $57.56, while YPHDF trades at $439.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas YPHDF's P/E ratio is 21.34. In terms of profitability, CLPBF's ROE is +0.14%, compared to YPHDF's ROE of +0.38%. Regarding short-term risk, CLPBF and YPHDF have similar daily volatility (0.00).Check YPHDF's competition here
CLPBF vs GNGBY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, GNGBY has a market cap of 5.5B. Regarding current trading prices, CLPBF is priced at $57.56, while GNGBY trades at $20.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas GNGBY's P/E ratio is 22.10. In terms of profitability, CLPBF's ROE is +0.14%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, CLPBF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check GNGBY's competition here
CLPBF vs GNGBF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, CLPBF is priced at $57.56, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas GNGBF's P/E ratio is 21.79. In terms of profitability, CLPBF's ROE is +0.14%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, CLPBF and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
CLPBF vs CHEOF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CHEOF has a market cap of 4.8B. Regarding current trading prices, CLPBF is priced at $57.56, while CHEOF trades at $73.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CHEOF's P/E ratio is 19.41. In terms of profitability, CLPBF's ROE is +0.14%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, CLPBF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CHEOF's competition here
CLPBF vs CHEOY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CHEOY has a market cap of 4.7B. Regarding current trading prices, CLPBF is priced at $57.56, while CHEOY trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CHEOY's P/E ratio is 19.28. In terms of profitability, CLPBF's ROE is +0.14%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, CLPBF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CHEOY's competition here
CLPBF vs NHNKY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, NHNKY has a market cap of 2.8B. Regarding current trading prices, CLPBF is priced at $57.56, while NHNKY trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas NHNKY's P/E ratio is 15.41. In terms of profitability, CLPBF's ROE is +0.14%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, CLPBF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check NHNKY's competition here
CLPBF vs AMFPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AMFPF has a market cap of 2.6B. Regarding current trading prices, CLPBF is priced at $57.56, while AMFPF trades at $12.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AMFPF's P/E ratio is 33.36. In terms of profitability, CLPBF's ROE is +0.14%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, CLPBF and AMFPF have similar daily volatility (0.00).Check AMFPF's competition here
CLPBF vs AMBBY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, CLPBF is priced at $57.56, while AMBBY trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AMBBY's P/E ratio is 35.64. In terms of profitability, CLPBF's ROE is +0.14%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, CLPBF and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here
CLPBF vs AMBFF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, CLPBF is priced at $57.56, while AMBFF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, CLPBF's ROE is +0.14%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, CLPBF and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here
CLPBF vs OSSFF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, CLPBF is priced at $57.56, while OSSFF trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, CLPBF's ROE is +0.14%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, CLPBF and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here
CLPBF vs DRWKF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, CLPBF is priced at $57.56, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DRWKF's P/E ratio is 11.81. In terms of profitability, CLPBF's ROE is +0.14%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, CLPBF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check DRWKF's competition here
CLPBF vs GGNDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, CLPBF is priced at $57.56, while GGNDF trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas GGNDF's P/E ratio is 51.25. In terms of profitability, CLPBF's ROE is +0.14%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, CLPBF and GGNDF have similar daily volatility (0.00).Check GGNDF's competition here
CLPBF vs GNNDY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, CLPBF is priced at $57.56, while GNNDY trades at $42.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas GNNDY's P/E ratio is 51.05. In terms of profitability, CLPBF's ROE is +0.14%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, CLPBF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check GNNDY's competition here
CLPBF vs MCRPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, MCRPF has a market cap of 1.8B. Regarding current trading prices, CLPBF is priced at $57.56, while MCRPF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas MCRPF's P/E ratio is -10.62. In terms of profitability, CLPBF's ROE is +0.14%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, CLPBF and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
CLPBF vs DWRKF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, CLPBF is priced at $57.56, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CLPBF's ROE is +0.14%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CLPBF and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
CLPBF vs NHNKF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, CLPBF is priced at $57.56, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, CLPBF's ROE is +0.14%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, CLPBF and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here
CLPBF vs MEDGF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, CLPBF is priced at $57.56, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CLPBF's ROE is +0.14%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, CLPBF and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
CLPBF vs BOEUF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, CLPBF is priced at $57.56, while BOEUF trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BOEUF's P/E ratio is 86.17. In terms of profitability, CLPBF's ROE is +0.14%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, CLPBF is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check BOEUF's competition here
CLPBF vs OSSUY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, CLPBF is priced at $57.56, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, CLPBF's ROE is +0.14%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, CLPBF and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here
CLPBF vs FDMDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, FDMDF has a market cap of 1.6B. Regarding current trading prices, CLPBF is priced at $57.56, while FDMDF trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas FDMDF's P/E ratio is -9.17. In terms of profitability, CLPBF's ROE is +0.14%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, CLPBF and FDMDF have similar daily volatility (0.00).Check FDMDF's competition here
CLPBF vs VTRLY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, CLPBF is priced at $57.56, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas VTRLY's P/E ratio is -2.79. In terms of profitability, CLPBF's ROE is +0.14%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, CLPBF and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
CLPBF vs MDRSF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, CLPBF is priced at $57.56, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, CLPBF's ROE is +0.14%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, CLPBF and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here
CLPBF vs DGWPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, CLPBF is priced at $57.56, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DGWPF's P/E ratio is 7.62. In terms of profitability, CLPBF's ROE is +0.14%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, CLPBF and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here
CLPBF vs XVIPY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, XVIPY has a market cap of 898.2M. Regarding current trading prices, CLPBF is priced at $57.56, while XVIPY trades at $7.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas XVIPY's P/E ratio is N/A. In terms of profitability, CLPBF's ROE is +0.14%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, CLPBF and XVIPY have similar daily volatility (0.00).Check XVIPY's competition here
CLPBF vs LFTSF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, CLPBF is priced at $57.56, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, CLPBF's ROE is +0.14%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, CLPBF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check LFTSF's competition here
CLPBF vs ELEAF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, CLPBF is priced at $57.56, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ELEAF's P/E ratio is 12.31. In terms of profitability, CLPBF's ROE is +0.14%, compared to ELEAF's ROE of +0.17%. Regarding short-term risk, CLPBF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check ELEAF's competition here
CLPBF vs BRSYF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BRSYF has a market cap of 675.2M. Regarding current trading prices, CLPBF is priced at $57.56, while BRSYF trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BRSYF's P/E ratio is 76.55. In terms of profitability, CLPBF's ROE is +0.14%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, CLPBF and BRSYF have similar daily volatility (0.00).Check BRSYF's competition here
CLPBF vs XVIPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, CLPBF is priced at $57.56, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas XVIPF's P/E ratio is 76.60. In terms of profitability, CLPBF's ROE is +0.14%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, CLPBF is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check XVIPF's competition here
CLPBF vs IOBCF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, IOBCF has a market cap of 589.5M. Regarding current trading prices, CLPBF is priced at $57.56, while IOBCF trades at $20.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas IOBCF's P/E ratio is 41.02. In terms of profitability, CLPBF's ROE is +0.14%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, CLPBF and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
CLPBF vs AVMR Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, CLPBF is priced at $57.56, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CLPBF's ROE is +0.14%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, CLPBF and AVMR have similar daily volatility (0.00).Check AVMR's competition here
CLPBF vs CALZF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CALZF has a market cap of 414.5M. Regarding current trading prices, CLPBF is priced at $57.56, while CALZF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CALZF's P/E ratio is 60.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, CLPBF and CALZF have similar daily volatility (0.00).Check CALZF's competition here
CLPBF vs CYBQY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CYBQY has a market cap of 385.2M. Regarding current trading prices, CLPBF is priced at $57.56, while CYBQY trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CYBQY's P/E ratio is -216.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, CLPBF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CYBQY's competition here
CLPBF vs HYBT Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, CLPBF is priced at $57.56, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas HYBT's P/E ratio is N/A. In terms of profitability, CLPBF's ROE is +0.14%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, CLPBF and HYBT have similar daily volatility (0.00).Check HYBT's competition here
CLPBF vs CLVSF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, CLPBF is priced at $57.56, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CLVSF's P/E ratio is 22.48. In terms of profitability, CLPBF's ROE is +0.14%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, CLPBF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CLVSF's competition here
CLPBF vs CSSPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CSSPF has a market cap of 273.6M. Regarding current trading prices, CLPBF is priced at $57.56, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, CLPBF's ROE is +0.14%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, CLPBF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check CSSPF's competition here
CLPBF vs DMTRF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DMTRF has a market cap of 270.5M. Regarding current trading prices, CLPBF is priced at $57.56, while DMTRF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DMTRF's P/E ratio is -112.50. In terms of profitability, CLPBF's ROE is +0.14%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, CLPBF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check DMTRF's competition here
CLPBF vs EBRCZ Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, EBRCZ has a market cap of 262.3M. Regarding current trading prices, CLPBF is priced at $57.56, while EBRCZ trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas EBRCZ's P/E ratio is -1.68. In terms of profitability, CLPBF's ROE is +0.14%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, CLPBF and EBRCZ have similar daily volatility (0.00).Check EBRCZ's competition here
CLPBF vs CYBQF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CYBQF has a market cap of 248.8M. Regarding current trading prices, CLPBF is priced at $57.56, while CYBQF trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CYBQF's P/E ratio is -186.50. In terms of profitability, CLPBF's ROE is +0.14%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, CLPBF and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
CLPBF vs HTLZF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, CLPBF is priced at $57.56, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CLPBF's ROE is +0.14%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, CLPBF and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
CLPBF vs IMPZY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, CLPBF is priced at $57.56, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CLPBF's ROE is +0.14%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, CLPBF and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
CLPBF vs VMTHF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, CLPBF is priced at $57.56, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, CLPBF's ROE is +0.14%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, CLPBF and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
CLPBF vs BCCOY Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, CLPBF is priced at $57.56, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BCCOY's P/E ratio is -1.16. In terms of profitability, CLPBF's ROE is +0.14%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, CLPBF and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here
CLPBF vs DTXMF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, CLPBF is priced at $57.56, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, CLPBF's ROE is +0.14%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, CLPBF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check DTXMF's competition here
CLPBF vs EKDHF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, CLPBF is priced at $57.56, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, CLPBF and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here
CLPBF vs EAPIF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, EAPIF has a market cap of 163.4M. Regarding current trading prices, CLPBF is priced at $57.56, while EAPIF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas EAPIF's P/E ratio is -0.66. In terms of profitability, CLPBF's ROE is +0.14%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, CLPBF and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here
CLPBF vs JMDMF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, JMDMF has a market cap of 156.4M. Regarding current trading prices, CLPBF is priced at $57.56, while JMDMF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas JMDMF's P/E ratio is 83.33. In terms of profitability, CLPBF's ROE is +0.14%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CLPBF and JMDMF have similar daily volatility (0.00).Check JMDMF's competition here
CLPBF vs CLLKF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, CLPBF is priced at $57.56, while CLLKF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CLLKF's P/E ratio is -0.89. In terms of profitability, CLPBF's ROE is +0.14%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, CLPBF and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here
CLPBF vs AMEUF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, CLPBF is priced at $57.56, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CLPBF's ROE is +0.14%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, CLPBF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check AMEUF's competition here
CLPBF vs PXMBF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, CLPBF is priced at $57.56, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, CLPBF's ROE is +0.14%, compared to PXMBF's ROE of -0.03%. Regarding short-term risk, CLPBF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check PXMBF's competition here
CLPBF vs SOMNF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, CLPBF is priced at $57.56, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, CLPBF and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
CLPBF vs RSHUF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, CLPBF is priced at $57.56, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CLPBF's ROE is +0.14%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, CLPBF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check RSHUF's competition here
CLPBF vs AVHHL Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, CLPBF is priced at $57.56, while AVHHL trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas AVHHL's P/E ratio is -2.34. In terms of profitability, CLPBF's ROE is +0.14%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, CLPBF and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here
CLPBF vs CKMTF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, CLPBF is priced at $57.56, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CLPBF's ROE is +0.14%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, CLPBF and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
CLPBF vs SNZZF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, SNZZF has a market cap of 75.2M. Regarding current trading prices, CLPBF is priced at $57.56, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas SNZZF's P/E ratio is -5.32. In terms of profitability, CLPBF's ROE is +0.14%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, CLPBF and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here
CLPBF vs BLOZF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BLOZF has a market cap of 54.8M. Regarding current trading prices, CLPBF is priced at $57.56, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BLOZF's P/E ratio is -11.17. In terms of profitability, CLPBF's ROE is +0.14%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, CLPBF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check BLOZF's competition here
CLPBF vs TLTFF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, TLTFF has a market cap of 50.3M. Regarding current trading prices, CLPBF is priced at $57.56, while TLTFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas TLTFF's P/E ratio is -17.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to TLTFF's ROE of -2.42%. Regarding short-term risk, CLPBF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check TLTFF's competition here
CLPBF vs BRNHF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, CLPBF is priced at $57.56, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, CLPBF's ROE is +0.14%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CLPBF and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here
CLPBF vs NVYTF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, CLPBF is priced at $57.56, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, CLPBF's ROE is +0.14%, compared to NVYTF's ROE of -1.16%. Regarding short-term risk, CLPBF and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
CLPBF vs ACIXF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ACIXF has a market cap of 31.5M. Regarding current trading prices, CLPBF is priced at $57.56, while ACIXF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ACIXF's P/E ratio is -2.80. In terms of profitability, CLPBF's ROE is +0.14%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, CLPBF and ACIXF have similar daily volatility (0.00).Check ACIXF's competition here
CLPBF vs RDGL Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RDGL has a market cap of 30.4M. Regarding current trading prices, CLPBF is priced at $57.56, while RDGL trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RDGL's P/E ratio is -6.15. In terms of profitability, CLPBF's ROE is +0.14%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, CLPBF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check RDGL's competition here
CLPBF vs POSC Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, POSC has a market cap of 26.4M. Regarding current trading prices, CLPBF is priced at $57.56, while POSC trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas POSC's P/E ratio is -5.59. In terms of profitability, CLPBF's ROE is +0.14%, compared to POSC's ROE of -7.67%. Regarding short-term risk, CLPBF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check POSC's competition here
CLPBF vs MKEAF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, CLPBF is priced at $57.56, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CLPBF's ROE is +0.14%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, CLPBF and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
CLPBF vs TCLIF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, CLPBF is priced at $57.56, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, CLPBF's ROE is +0.14%, compared to TCLIF's ROE of +2.22%. Regarding short-term risk, CLPBF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check TCLIF's competition here
CLPBF vs KBBTF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, CLPBF is priced at $57.56, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CLPBF's ROE is +0.14%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CLPBF and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
CLPBF vs EMITF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, CLPBF is priced at $57.56, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas EMITF's P/E ratio is -7.62. In terms of profitability, CLPBF's ROE is +0.14%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, CLPBF and EMITF have similar daily volatility (0.00).Check EMITF's competition here
CLPBF vs PYNKF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, PYNKF has a market cap of 20M. Regarding current trading prices, CLPBF is priced at $57.56, while PYNKF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas PYNKF's P/E ratio is 3.58. In terms of profitability, CLPBF's ROE is +0.14%, compared to PYNKF's ROE of -3.36%. Regarding short-term risk, CLPBF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check PYNKF's competition here
CLPBF vs DIZTF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, CLPBF is priced at $57.56, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, CLPBF's ROE is +0.14%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, CLPBF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check DIZTF's competition here
CLPBF vs VPTDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, VPTDF has a market cap of 16.2M. Regarding current trading prices, CLPBF is priced at $57.56, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas VPTDF's P/E ratio is -8.63. In terms of profitability, CLPBF's ROE is +0.14%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, CLPBF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check VPTDF's competition here
CLPBF vs GTHP Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, GTHP has a market cap of 15.3M. Regarding current trading prices, CLPBF is priced at $57.56, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas GTHP's P/E ratio is -5.00. In terms of profitability, CLPBF's ROE is +0.14%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, CLPBF and GTHP have similar daily volatility (0.00).Check GTHP's competition here
CLPBF vs MDXHF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, CLPBF is priced at $57.56, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, CLPBF's ROE is +0.14%, compared to MDXHF's ROE of +0.62%. Regarding short-term risk, CLPBF and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here
CLPBF vs TMDIF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, CLPBF is priced at $57.56, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CLPBF's ROE is +0.14%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, CLPBF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check TMDIF's competition here
CLPBF vs ASAPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ASAPF has a market cap of 12.3M. Regarding current trading prices, CLPBF is priced at $57.56, while ASAPF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ASAPF's P/E ratio is -15.80. In terms of profitability, CLPBF's ROE is +0.14%, compared to ASAPF's ROE of -0.15%. Regarding short-term risk, CLPBF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check ASAPF's competition here
CLPBF vs ATBPF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, CLPBF is priced at $57.56, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CLPBF's ROE is +0.14%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CLPBF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check ATBPF's competition here
CLPBF vs ALRTF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ALRTF has a market cap of 11.4M. Regarding current trading prices, CLPBF is priced at $57.56, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ALRTF's P/E ratio is -0.44. In terms of profitability, CLPBF's ROE is +0.14%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CLPBF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check ALRTF's competition here
CLPBF vs LXXGF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, CLPBF is priced at $57.56, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CLPBF's ROE is +0.14%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CLPBF and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
CLPBF vs IPDQF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, IPDQF has a market cap of 10.5M. Regarding current trading prices, CLPBF is priced at $57.56, while IPDQF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas IPDQF's P/E ratio is -0.45. In terms of profitability, CLPBF's ROE is +0.14%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, CLPBF and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here
CLPBF vs PLLWF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, CLPBF is priced at $57.56, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, CLPBF's ROE is +0.14%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, CLPBF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check PLLWF's competition here
CLPBF vs BIEL Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, BIEL has a market cap of 6.3M. Regarding current trading prices, CLPBF is priced at $57.56, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas BIEL's P/E ratio is N/A. In terms of profitability, CLPBF's ROE is +0.14%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, CLPBF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check BIEL's competition here
CLPBF vs PMEDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, PMEDF has a market cap of 5.6M. Regarding current trading prices, CLPBF is priced at $57.56, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas PMEDF's P/E ratio is -2.71. In terms of profitability, CLPBF's ROE is +0.14%, compared to PMEDF's ROE of +1.43%. Regarding short-term risk, CLPBF and PMEDF have similar daily volatility (0.00).Check PMEDF's competition here
CLPBF vs QLIS Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, CLPBF is priced at $57.56, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CLPBF's ROE is +0.14%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, CLPBF and QLIS have similar daily volatility (0.00).Check QLIS's competition here
CLPBF vs RHNMF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, CLPBF is priced at $57.56, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CLPBF's ROE is +0.14%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, CLPBF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check RHNMF's competition here
CLPBF vs ADMT Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, ADMT has a market cap of 4.7M. Regarding current trading prices, CLPBF is priced at $57.56, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas ADMT's P/E ratio is -6.90. In terms of profitability, CLPBF's ROE is +0.14%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, CLPBF and ADMT have similar daily volatility (0.00).Check ADMT's competition here
CLPBF vs RMSL Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, RMSL has a market cap of 4.6M. Regarding current trading prices, CLPBF is priced at $57.56, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas RMSL's P/E ratio is 0.27. In terms of profitability, CLPBF's ROE is +0.14%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, CLPBF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check RMSL's competition here
CLPBF vs USAQ Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, USAQ has a market cap of 3.7M. Regarding current trading prices, CLPBF is priced at $57.56, while USAQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas USAQ's P/E ratio is 10.08. In terms of profitability, CLPBF's ROE is +0.14%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, CLPBF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check USAQ's competition here
CLPBF vs NGMDF Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, NGMDF has a market cap of 3.6M. Regarding current trading prices, CLPBF is priced at $57.56, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas NGMDF's P/E ratio is -0.53. In terms of profitability, CLPBF's ROE is +0.14%, compared to NGMDF's ROE of +0.99%. Regarding short-term risk, CLPBF and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here
CLPBF vs VANIW Comparison June 2026
CLPBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBF stands at 11.9B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, CLPBF is priced at $57.56, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBF currently has a P/E ratio of 39.70, whereas VANIW's P/E ratio is N/A. In terms of profitability, CLPBF's ROE is +0.14%, compared to VANIW's ROE of -2.64%. Regarding short-term risk, CLPBF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBF.Check VANIW's competition here